Or wait…
Sign in Register
News
Manufacturers
Suppliers
Research
Markets
Regulation
People
Views
Promotional Features
Site Archive
Multimedia
Trends
Coronavirus
CBD / Hemp
Probiota Americas
Sports Nutrition Summit
DSHEA at 25
Supply Chain Management
Media & industry critics
Personalized Nutrition
GMPs, QA & QC
NDI draft guidance
Regulations, Legislation & Enforcement
The changing retail landscape
Outsourcing
M&A
Site Archive
Multimedia
Health
Type of resources
Resources
Type of resources
Events
All Events
Online Events
Editorial Webinars
Shows & Conferences
Events
Reports
Podcast
By Danielle Masterson
15-Mar-2022 – Last updated on 15-Mar-2022 at 14:32 GMT
Related tags: Cbd, Fda, Pediatrics
function sanitize_gpt_value2(gptValue)
{
var vOut = “”;
var aTags = gptValue.split(‘,’);
var reg = new RegExp(‘\W+’, “g”);
for (var i=0; i < aTags.length; i++)
{
vOut += aTags[i].trim().replace(reg, '-').substring(0,40);
if (i!=(aTags.length-1))
vOut +=', ';
}
vOut = vOut.toLowerCase();
return vOut;
}
$(document).ready(function() {
dataLayerNews = {};
dataLayerNews.related_tags = sanitize_gpt_value2("Cbd, Fda, Pediatrics");
dataLayer.push(dataLayerNews);
});
The University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health survey revealed that parents have limited knowledge about CBD, with a third thinking it’s the same as using marijuana.
The parents who have or would consider giving their child CBD cite anxiety, sleep, and ADHD as top reasons for doing so.
The nationally representative poll report is based on responses from about 2,000 parents of children 3-18 years surveyed in October 2021.
Knowledge gap
Nearly half (46%) of parents say they either don’t know much about CBD use in children or they never heard of it prior to the poll (34%); 17% report having some knowledge, and 3% said they know a lot about CBD use in children. Most parents (71%) have never used a CBD product themselves, while 24% have tried CBD and 5% use a CBD product regularly.
Safety
Parents say the factors that would be very important in deciding whether to give their child a CBD product are side effects (83%), if it was tested for safety in children (78%), how well it works in children (72%), recommendation of their child’s doctor (63%), approval of the US Food and Drug Administration (58%), and product reviews (41%).
Alternative to meds
About three-quarters of parents (73%) think CBD may be a good option for children when other medications don’t work. Most parents (83%) reported that CBD products should be regulated by the FDA, and three-quarters (74%) said CBD for children should require a doctor’s prescription. One-third of parents (35%) think taking CBD is basically the same as using marijuana.
Condition specific
Parents’ most common reasons for giving or considering CBD for their child include anxiety (51%), sleep problems (40%), ADHD (33%), muscle pain (20%), autism (19%), and to make their child feel better in general (13%).
Among parents who have given or considered giving CBD for their child, 29% say they talked with their child’s healthcare provider about CBD use.
Usage
Over 90% of parents have never given or considered giving their child a CBD product. Just 2% have given their child a CBD product, while 4% have considered CBD for their child; 1% reported their child used CBD without their permission.
“There is only one FDA-approved drug derived from a pure form of CBD oil, Epidiolex, which has proven effective in reducing seizures in some severe types of epilepsy,” said Washington University physician Jennifer Griffith, MD, PhD, a pediatric neurologist at St. Louis Children’s Hospital. “Other than that, there have been no well-designed, randomized controlled trials to tell us if CBD is safe and effective for other conditions like mood disorders, inflammatory conditions or pain. And there is no data on its effects after long-term use.”
“Regulation at the federal level is needed to ensure that we grow, extract, manufacture and test products that are marketed to the public. This combined with scientific research will continue to boost the consumer knowledge base and consumer confidence in the best ways to use this amazing product,” noted David Tracek, CEO of Basso Botanicals, a Scottsdale-based CBD brand. “Just like there are many myths about cannabis, people also have their own misconceptions when it comes to CBD. Misconception number one is that you will get high from taking this chemical in your system; however, nothing can be further than the truth. Unlike THC, which produces psychoactivity, cannabidiol only has non-psychoactive effects such as relaxation and pain relief.”
While it is impossible to overdose on pure CBD, acute poisoning has been reported with synthetic CBD. In 2017, over 50 people experienced adverse reactions inconsistent with known CBD effects. The culprit was later identified as the synthetic cannabinoid, 4-cyano CUMYL-BUTINACA (4-CCB).
Chase Terwilliger, CEO of CBDistillery, said the poll showing parent’s lack of understanding for CBD products is illuminating, but not at all surprising. “Our industry has come a long way but we know there is still a lot of consumer education that needs to take place. While some companies in our industry are working hard to keep the integrity of CBD products and contribute to consumer knowledge and understanding, there are many illegitimate companies who are selling unsafe products and distributing distorted information on cannabinoids. This is a major reason why federal regulation is needed in our industry, to keep both consumers safe and to keep a clean marketplace where factual information is not buried by misleading information,” said Terwilliger. “While we know and believe in the power of CBD, there is a lot of research and federal regulation needed before such products can be administered to children.”
Although three-quarters of parents reported that CBD for children should require a prescription, only 63% rated the recommendation of their child’s doctor as a very important factor in deciding whether to give their child a CBD product. Moreover, among parents who tried or considered CBD for their child, only 29% discussed the topic with their child’s healthcare provider.
It’s also worth noting that some medical centers have policies banning CBD prescriptions, so treatment options vary depending on location.
Copyright – Unless otherwise stated all contents of this web site are © 2022 – William Reed Ltd – All Rights Reserved – Full details for the use of materials on this site can be found in the Terms & Conditions
Related topics: Research, Maternal & infant health, CBD / Hemp, Botanicals
Show more
A breakthrough in the nutraceutical industry reveals a new highly effective clinically tested herbal formula that significantly improves joint health in…
Clinical studies have shown that Pycnogenol®, French maritime pine bark extract has a positive effect on endothelial functions, normalizes blood pressure,…
VIVACOAT® free is the Titanium Dioxide free ready-to-use coating system designed for Pharmaceutical and Nutraceutical formulations.
KaraLiv™ is a patent-pending and clinically tested vegan herbal blend that promotes liver function in 30 days. After extensive R&D and exploration…
Show more
Upcoming supplier webinars
On-demand webinars
More promotional features
